mRNA |
Irinotecan |
FIMM |
pan-cancer |
AAC |
0.38 |
0.0003 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0007 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |